Related references
Note: Only part of the references are listed.The Discovery of Salinosporamide K from the Marine Bacterium Salinispora pacifica by Genome Mining Gives Insight into Pathway Evolution
Alessandra S. Eustaquio et al.
CHEMBIOCHEM (2011)
Genome mining for ribosomally synthesized natural products
Juan E. Velasquez et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2011)
FRESH FROM THE PIPELINE Eribulin mesylate
Timothy K. Huyck et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Identification of a bioactive 51-membered macrolide complex by activation of a silent polyketide synthase in Streptomyces ambofaciens
Luisa Laureti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Antibody-drug conjugates: using monoclonal antibodies for delivery of cytotoxic payloads to cancer cells
Victor S. Goldmacher et al.
THERAPEUTIC DELIVERY (2011)
Improvement of secondary metabolite production in Streptomyces by manipulating pathway regulation
Yihua Chen et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2010)
Antibody-Drug Conjugates: Linking Cytotoxic Payloads to Monoclonal Antibodies
Laurent Ducry et al.
BIOCONJUGATE CHEMISTRY (2010)
Natural Products Version 2.0: Connecting Genes to Molecules
Christopher T. Walsh et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Polyketide synthase chemistry does not direct biosynthetic divergence between 9-and 10-membered enediynes
Geoff P. Horsman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Engineered Streptomyces platensis Strains That Overproduce Antibiotics Platensimycin and Platencin
Michael J. Smanski et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Recent advances in the chemistry, biosynthesis and pharmacology of rapamycin analogs
Edmund I. Graziani
NATURAL PRODUCT REPORTS (2009)
Pharmaceutical industry financial performance
Michael Goodman
NATURE REVIEWS DRUG DISCOVERY (2009)
Function-oriented synthesis, step economy, and drug design
Paul A. Wender et al.
ACCOUNTS OF CHEMICAL RESEARCH (2008)
Optimizing natural products by biosynthetic engineering: Discovery of nonquinone Hsp90 inhibitors
Ming-Qiang Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Pre-fractionated microbial samples - The second generation natural products library at Wyeth
Melissa M. Wagenaar
MOLECULES (2008)
Network pharmacology: the next paradigm in drug discovery
Andrew L. Hopkins
NATURE CHEMICAL BIOLOGY (2008)
The exploration of macrocycles for drug discovery - an underexploited structural class
Edward M. Driggers et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Reaching for high-hanging fruit in drug discovery at protein-protein interfaces
James A. Wells et al.
NATURE (2007)
Scaffolds for blocking protein-protein interactions
Stefan J. Hershberger et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2007)
From natural products discovery to commercialization: a success story
Arnold L. Dernain
JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY (2006)
Designed multiple ligands. An emerging drug discovery paradigm
R Morphy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
FKBP immunophilin patents for neurological disorders
RE Babine et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2005)
Semi-synthetic DNA shuffling of aveC leads to improved industrial scale production of doramectin by Streptomyces avermitilis
K Stutzman-Engwall et al.
METABOLIC ENGINEERING (2005)
Small-molecule inhibitors of protein-protein interactions: Progressing towards the dream
MR Arkin et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Macrocyclic ketone analogues of halichondrin B
WJ Zheng et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Neuroimmunophilins: A novel drug therapy for the reversal of neurodegenerative disease?
MO Poulter et al.
NEUROSCIENCE (2004)
A genomics-guided approach for discovering and expressing cryptic metabolic pathways
E Zazopoulos et al.
NATURE BIOTECHNOLOGY (2003)
Gemtuzumab ozogamicin, a potent and selective anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia
PR Hamann et al.
BIOCONJUGATE CHEMISTRY (2002)